Abstract
Apraxia of speech (AOS) is a motor disorder that occurs as a result of impairment in the planning or programming of movements for speech production. It is typically associated with cerebrovascular events, although it can also occur in the context of neurodegeneration where its importance has typically been deemphasized to “just a component of a presenting syndrome.” Primary progressive aphasia (PPA) is such a syndrome in which AOS coexists with other linguistic deficits, typically agrammatic aphasia. Recently, however, AOS has been demonstrated to occur in a pure or isolated form, known as primary progressive apraxia of speech (PPAOS), reaffirming the importance of neurodegenerative AOS. Furthermore, anatomic and pathologic associations differ between AOS-dominant syndromes and PPA variants. Understanding the relationship between AOS-dominant variants, including PPAOS and PPA, and their relationship to movement disorders including corticobasal degeneration and progressive supranuclear palsy, is important and will be the focus of this chapter.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Acosta-Cabronero J, Patterson K, Fryer TD, Hodges JR, Pengas G, et al. Atrophy, hypometabolism and white matter abnormalities in semantic dementia tell a coherent story. Brain. 2012;134:2025–35.
Adeli A, Whitwell JL, Duffy JR, Strand EA, Josephs KA. Ideomotor apraxia in agrammatic and logopenic variants of primary progressive aphasia. J Neurol. 2013;260:1594–600.
Agosta F, Henry RG, Migliaccio R, Neuhaus J, Miller BL, et al. Language networks in semantic dementia. Brain. 2010;133:286–99.
Armstrong MJ, Litvan I, Lang AE, Bak TH, Bhatia KP, et al. Criteria for the diagnosis of corticobasal degeneration. Neurology. 2013;80:496–503.
Assal F, Laganaro M, Remund CD, Ragno Paquier C. Progressive crossed-apraxia of speech as a first manifestation of a probable corticobasal degeneration. Behav Neurol. 2012;25:285–9.
Boeve BF, Boylan KB, Graff-Radford NR, DeJesus-Hernandez M, Knopman DS, et al. Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72. Brain. 2012;135:765–83.
Borroni B, Garibotto V, Agosti C, Brambati SM, Bellelli G, et al. White matter changes in corticobasal degeneration syndrome and correlation with limb apraxia. Arch Neurol. 2008;65:796–801.
Boxer AL, Geschwind MD, Belfor N, Gorno-Tempini ML, Schauer GF, et al. Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy. Arch Neurol. 2006;63:81–6.
Broussolle E, Tommasi M, Mauguiere F, Chazot G. Progressive anarthria with secondary parkinsonism: a clinico-pathological case report. J Neurol Neurosurg Psychiatry. 1992;55:577–80.
Caselli RJ, Windebank AJ, Petersen RC, Komori T, Parisi JE, et al. Rapidly progressive aphasic dementia and motor neuron disease. Ann Neurol. 1993;33:200–7.
Caselli RJ, Beach TG, Sue LI, Connor DJ, Sabbagh MN. Dement Geriatr Cogn Disord. 2002;14:55–8.
Chan D, Fox NC, Scahill RI, Crum WR, Whitwell JL, et al. Patterns of temporal lobe atrophy in semantic dementia and Alzheimer’s disease. Ann Neurol. 2001;49:433–42.
Chan D, Anderson V, Pijnenburg Y, Whitwell J, Barnes J, et al. The clinical profile of right temporal lobe atrophy. Brain. 2009;132:1287–98.
Coon EA, Sorenson EJ, Whitwell JL, Knopman DS, Josephs KA. Predicting survival in frontotemporal dementia with motor neuron disease. Neurology. 2011;76:1886–93.
Czell D, Andersen PM, Neuwirth C, Morita M, Weber M. Progressive aphasia as the presenting symptom in a patient with amyotrophic lateral sclerosis with a novel mutation in the OPTN gene. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14:138–40.
da Rocha AJ, Valerio BC, Buainain RP, Ferraz ME, da Silva CJ, et al. Motor neuron disease associated with non-fluent rapidly progressive aphasia: case report and review of the literature. Eur J Neurol. 2007;14:971–5.
Darley FL, Aronson AE, Brown JR. Differential diagnostic patterns of dysarthria. J Speech Hear Res. 1969;12:246–69.
Darley FL, Aronson AE, Brown JR. Motor speech disorders. Philadelphia: W.B. Saunders; 1975.
Davies RR, Hodges JR, Kril JJ, Patterson K, Halliday GM, et al. The pathological basis of semantic dementia. Brain. 2005;128:1984–95.
Deramecourt V, Lebert F, Debachy B, Mackowiak-Cordoliani MA, Bombois S, et al. Prediction of pathology in primary progressive language and speech disorders. Neurology. 2010;74:42–9.
Dickson DW. Neuropathology of Pick’s disease. Neurology. 2001;56:S16–20.
Dickson DW. Neurodegeneration: the molecular pathology of dementia and movement disorders. Basel: ISN Neuropath Press; 2003.
Dickson DW, Bergeron C, Chin SS, Duyckaerts C, Horoupian D, et al. Office of Rare Diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol. 2002;61:935–46.
Duffy J. Apraxia of speech in degenerative neurologic disease. Aphasiology. 2006;20:511–27.
Duffy JR. Motor speech disorders: substrates, differential diagnosis, and management. St Louis: Mosby; 2013.
Duffy JR, Peach RK, Strand EA. Progressive apraxia of speech as a sign of motor neuron disease. Am J Speech Lang Pathol. 2007;16:198–208.
Edwards-Lee T, Miller BL, Benson DF, Cummings JL, Russell GL, et al. The temporal variant of frontotemporal dementia. Brain. 1997;120(Pt 6):1027–40.
Galantucci S, Tartaglia MC, Wilson SM, Henry ML, Filippi M, et al. White matter damage in primary progressive aphasias: a diffusion tensor tractography study. Brain. 2011;134:3011–29.
Galton CJ, Patterson K, Xuereb JH, Hodges JR. Atypical and typical presentations of Alzheimer’s disease: a clinical, neuropsychological, neuroimaging and pathological study of 13 cases. Brain. 2000;123(Pt 3):484–98.
Galton CJ, Patterson K, Graham K, Lambon-Ralph MA, Williams G, et al. Differing patterns of temporal atrophy in Alzheimer’s disease and semantic dementia. Neurology. 2001;57:216–25.
Ghetti B, Hutton M, Wszolek Z. Frontotemporal dementia and parkinsonism linked to chromosome 17 associated with tau gene mutations (FTDP-17T). In: Dickson D, editor. Neurodegeneration: the molecular pathology of dementia and movement disorders. Basel: ISN Neuropath Press; 2003. p. 86–102.
Gorno-Tempini ML, Dronkers NF, Rankin KP, Ogar JM, Phengrasamy L, et al. Cognition and anatomy in three variants of primary progressive aphasia. Ann Neurol. 2004;55:335–46.
Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, et al. Classification of primary progressive aphasia and its variants. Neurology. 2011;76:1006–14.
Graff-Radford NR, Damasio AR, Hyman BT, Hart MN, Tranel D, et al. Progressive aphasia in a patient with Pick’s disease: a neuropsychological, radiologic, and anatomic study. Neurology. 1990;40:620–6.
Graff-Radford J, Duffy JR, Strand EA, Josephs KA. Parkinsonian motor features distinguish the agrammatic from logopenic variant of primary progressive aphasia. Parkinsonism Relat Disord. 2012;18:890–2.
Greene JD, Patterson K, Xuereb J, Hodges JR. Alzheimer disease and nonfluent progressive aphasia. Arch Neurol. 1996;53:1072–8.
Groschel K, Hauser TK, Luft A, Patronas N, Dichgans J, et al. Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from corticobasal degeneration. Neuroimage. 2004;21:714–24.
Grossman M, McMillan C, Moore P, Ding L, Glosser G, et al. What’s in a name: voxel-based morphometric analyses of MRI and naming difficulty in Alzheimer’s disease, frontotemporal dementia and corticobasal degeneration. Brain. 2004;127:628–49.
Grossman M, Powers J, Ash S, McMillan C, Burkholder L, et al. Disruption of large-scale neural networks in non-fluent/agrammatic variant primary progressive aphasia associated with frontotemporal degeneration pathology. Brain Lang. 2013;127:106–20.
Hauw JJ, Daniel SE, Dickson D, Horoupian DS, Jellinger K, et al. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology. 1994;44:2015–9.
Hodges JR, Patterson K. Semantic dementia: a unique clinicopathological syndrome. Lancet Neurol. 2007;6:1004–14.
Hodges JR, Davies RR, Xuereb JH, Casey B, Broe M, et al. Clinicopathological correlates in frontotemporal dementia. Ann Neurol. 2004;56:399–406.
Huey ED, Pardini M, Cavanagh A, Wassermann EM, Kapogiannis D, et al. Association of ideomotor apraxia with frontal gray matter volume loss in corticobasal syndrome. Arch Neurol. 2009;66:1274–80.
Josephs KA, Duffy JR. Apraxia of speech and nonfluent aphasia: a new clinical marker for corticobasal degeneration and progressive supranuclear palsy. Curr Opin Neurol. 2008;21:688–92.
Josephs KA, Boeve BF, Duffy JR, Smith GE, Knopman DS, et al. Atypical progressive supranuclear palsy underlying progressive apraxia of speech and nonfluent aphasia. Neurocase. 2005;11:283–96.
Josephs KA, Duffy JR, Strand EA, Whitwell JL, Layton KF, et al. Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech. Brain. 2006a;129:1385–98.
Josephs KA, Petersen RC, Knopman DS, Boeve BF, Whitwell JL, et al. Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP. Neurology. 2006b;66:41–8.
Josephs KA, Whitwell JL, Dickson DW, Boeve BF, Knopman DS, et al. Voxel-based morphometry in autopsy proven PSP and CBD. Neurobiol Aging. 2008;29:280–9.
Josephs KA, Whitwell JL, Knopman DS, Boeve BF, Vemuri P, et al. Two distinct subtypes of right temporal variant frontotemporal dementia. Neurology. 2009a;73:1443–50.
Josephs KA, Stroh A, Dugger B, Dickson DW. Evaluation of subcortical pathology and clinical correlations in FTLD-U subtypes. Acta Neuropathol. 2009b;118:349–58.
Josephs KA, Duffy JR, Fossett TR, Strand EA, Claassen DO, et al. Fluorodeoxyglucose F18 positron emission tomography in progressive apraxia of speech and primary progressive aphasia variants. Arch Neurol. 2010;67:596–605.
Josephs KA, Hodges JR, Snowden JS, Mackenzie IR, Neumann M, et al. Neuropathological background of phenotypical variability in frontotemporal dementia. Acta Neuropathol. 2011;122:137–53.
Josephs KA, Duffy JR, Strand EA, Machulda MM, Senjem ML, et al. Characterizing a neurodegenerative syndrome: primary progressive apraxia of speech. Brain. 2012;135:1522–36.
Josephs KA, Duffy JR, Strand EA, Machulda MM, Senjem ML, et al. Syndromes dominated by apraxia of speech show distinct characteristics from agrammatic PPA. Neurology. 2013a;81:337–45.
Josephs KA, Whitwell JL, Murray ME, Parisi JE, Graff-Radford NR, et al. Corticospinal tract degeneration associated with TDP-43 type C pathology and semantic dementia. Brain. 2013b;136:455–70.
Kelley BJ, Haidar W, Boeve BF, Baker M, Graff-Radford NR, et al. Prominent phenotypic variability associated with mutations in Progranulin. Neurobiol Aging. 2009;30:739–51.
Kertesz A, Hudson L, Mackenzie IR, Munoz DG. The pathology and nosology of primary progressive aphasia. Neurology. 1994;44:2065–72.
Kertesz A, McMonagle P, Blair M, Davidson W, Munoz DG. The evolution and pathology of frontotemporal dementia. Brain. 2005;128:1996–2005.
Knake S, Belke M, Menzler K, Pilatus U, Eggert KM, et al. In vivo demonstration of microstructural brain pathology in progressive supranuclear palsy: a DTI study using TBSS. Mov Disord. 2010;25:1232–8.
Knibb JA, Xuereb JH, Patterson K, Hodges JR. Clinical and pathological characterization of progressive aphasia. Ann Neurol. 2006;59:156–65.
Knopman DS, Mastri AR, Frey 2nd WH, Sung JH, Rustan T. Dementia lacking distinctive histologic features: a common non-Alzheimer degenerative dementia. Neurology. 1990;40:251–6.
Koyama M, Yagishita A, Nakata Y, Hayashi M, Bandoh M, et al. Imaging of corticobasal degeneration syndrome. Neuroradiology. 2007;49:905–12.
Kremen SA, Mendez MF, Tsai P, Teng E. Extrapyramidal signs in the primary progressive aphasias. Am J Alzheimers Dis Other Demen. 2011;26:72–7.
Lang AE. Cortical basal ganglionic degeneration presenting with “progressive loss of speech output and orofacial dyspraxia”. J Neurol Neurosurg Psychiatry. 1992;55:1101.
Lippa CF, Cohen R, Smith TW, Drachman DA. Primary progressive aphasia with focal neuronal achromasia. Neurology. 1991;41:882–6.
Mackenzie IR, Baborie A, Pickering-Brown S, Du Plessis D, Jaros E, et al. Heterogeneity of ubiquitin pathology in frontotemporal lobar degeneration: classification and relation to clinical phenotype. Acta Neuropathol (Berl). 2006;112:539–49.
Mackenzie IR, Neumann M, Baborie A, Sampathu DM, Du Plessis D, et al. A harmonized classification system for FTLD-TDP pathology. Acta Neuropathol. 2011;122:111–3.
Madhavan A, Whitwell JL, Weigand SD, Duffy JR, Strand EA, et al. FDG PET and MRI in logopenic primary progressive aphasia versus dementia of the Alzheimer’s type. PLoS One. 2013;8:e62471.
Mahoney CJ, Beck J, Rohrer JD, Lashley T, Mok K, et al. Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features. Brain. 2012;135:736–50.
Mahoney CJ, Malone IB, Ridgway GR, Buckley AH, Downey LE, et al. White matter tract signatures of the progressive aphasias. Neurobiol Aging. 2013;34:1687–99.
Mesulam MM. Slowly progressive aphasia without generalized dementia. Ann Neurol. 1982;11:592–8.
Mesulam MM. Primary progressive aphasia. Ann Neurol. 2001;49:425–32.
Mesulam MM. Primary progressive aphasia–a language-based dementia. N Engl J Med. 2003;349:1535–42.
Mesulam M, Johnson N, Krefft TA, Gass JM, Cannon AD, et al. Progranulin mutations in primary progressive aphasia: the PPA1 and PPA3 families. Arch Neurol. 2007;64:43–7.
Mesulam M, Wicklund A, Johnson N, Rogalski E, Leger GC, et al. Alzheimer and frontotemporal pathology in subsets of primary progressive aphasia. Ann Neurol. 2008;63:709–19.
Mukherjee O, Pastor P, Cairns NJ, Chakraverty S, Kauwe JS, et al. HDDD2 is a familial frontotemporal lobar degeneration with ubiquitin-positive, tau-negative inclusions caused by a missense mutation in the signal peptide of progranulin. Ann Neurol. 2006;60:314–22.
Mummery CJ, Patterson K, Price CJ, Ashburner J, Frackowiak RS, et al. A voxel-based morphometry study of semantic dementia: relationship between temporal lobe atrophy and semantic memory. Ann Neurol. 2000;47:36–45.
Ogar J, Slama H, Dronkers N, Amici S, Gorno-Tempini ML. Apraxia of speech: an overview. Neurocase. 2005;11:427–32.
Pickering-Brown SM, Rollinson S, Du Plessis D, Morrison KE, Varma A, et al. Frequency and clinical characteristics of progranulin mutation carriers in the Manchester frontotemporal lobar degeneration cohort: comparison with patients with MAPT and no known mutations. Brain. 2008;131:721–31.
Ridgway GR, Lehmann M, Barnes J, Rohrer JD, Warren JD, et al. Early-onset alzheimer disease clinical variants: multivariate analyses of cortical thickness. Neurology. 2012;79:80–4.
Roh JH, Suh MK, Kim EJ, Go SM, Na DL, Seo SW. Glucose metabolism in progressive nonfluent aphasia with and without parkinsonism. Neurology. 2010;75:1022–4.
Rohrer JD, Warren JD, Modat M, Ridgway GR, Douiri A, et al. Patterns of cortical thinning in the language variants of frontotemporal lobar degeneration. Neurology. 2009;72:1562–9.
Rohrer JD, Crutch SJ, Warrington EK, Warren JD. Progranulin-associated primary progressive aphasia: a distinct phenotype? Neuropsychologia. 2010;48:288–97.
Schwindt GC, Graham NL, Rochon E, Tang-Wai DF, Lobaugh NJ, et al. Whole-brain white matter disruption in semantic and nonfluent variants of primary progressive aphasia. Hum Brain Mapp. 2013;34:973–84.
Simon-Sanchez J, Dopper EG, Cohn-Hokke PE, Hukema RK, Nicolaou N, et al. The clinical and pathological phenotype of C9ORF72 hexanucleotide repeat expansions. Brain. 2012;135:723–35.
Snowden JS, Pickering-Brown SM, Mackenzie IR, Richardson AM, Varma A, et al. Progranulin gene mutations associated with frontotemporal dementia and progressive non-fluent aphasia. Brain. 2006;129:3091–102.
Snowden J, Neary D, Mann D. Frontotemporal lobar degeneration: clinical and pathological relationships. Acta Neuropathol. 2007;114:31–8.
Snowden JS, Rollinson S, Thompson JC, Harris JM, Stopford CL, et al. Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations. Brain. 2012;135:693–708.
Soliveri P, Monza D, Paridi D, Radice D, Grisoli M, et al. Cognitive and magnetic resonance imaging aspects of corticobasal degeneration and progressive supranuclear palsy. Neurology. 1999;53:502–7.
Thompson SA, Patterson K, Hodges JR. Left/right asymmetry of atrophy in semantic dementia: behavioral-cognitive implications. Neurology. 2003;61:1196–203.
Warrington E. Selective impairment of semantic memory. Q J Exp Psychol. 1975;27:635–57.
Wechsler AF, Verity MA, Rosenschein S, Fried I, Scheibel AB. Pick’s disease. A clinical, computed tomographic, and histologic study with golgi impregnation observations. Arch Neurol. 1982;39:287–90.
Whitwell JL, Avula R, Senjem ML, Kantarci K, Weigand SD, et al. Gray and white matter water diffusion in the syndromic variants of frontotemporal dementia. Neurology. 2010a;74:1279–87.
Whitwell JL, Jack Jr CR, Boeve BF, Parisi JE, Ahlskog JE, et al. Imaging correlates of pathology in corticobasal syndrome. Neurology. 2010b;75:1879–87.
Whitwell JL, Master AV, Avula R, Kantarci K, Eggers SD, et al. Clinical correlates of white matter tract degeneration in progressive supranuclear palsy. Arch Neurol. 2011;68:753–60.
Whitwell JL, Duffy JR, Strand EA, Machulda MM, Senjem ML, et al. Neuroimaging comparison of primary progressive apraxia of speech and progressive supranuclear palsy. Eur J Neurol. 2013a;20:629–37.
Whitwell JL, Duffy JR, Strand EA, Xia R, Mandrekar J, et al. Distinct regional anatomic and functional correlates of neurodegenerative apraxia of speech and aphasia: an MRI and FDG-PET study. Brain Lang. 2013b;125:245–52.
Zhang Y, Schuff N, Du AT, Rosen HJ, Kramer JH, et al. White matter damage in frontotemporal dementia and Alzheimer’s disease measured by diffusion MRI. Brain. 2009;132:2579–92.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag London
About this chapter
Cite this chapter
Josephs, K.A., Whitwell, J.L. (2014). Progressive Apraxia of Speech and Primary Progressive Aphasias. In: Merello, M., Starkstein, S. (eds) Movement Disorders in Dementias. Springer, London. https://doi.org/10.1007/978-1-4471-6365-7_13
Download citation
DOI: https://doi.org/10.1007/978-1-4471-6365-7_13
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-6364-0
Online ISBN: 978-1-4471-6365-7
eBook Packages: MedicineMedicine (R0)